Why Choose Us Founded in 2012 by experienced large Pharma medicinal and computational chemists to accelerate drug hunting by exploiting data driven knowledge Domain leaders in SAR knowledge extraction Highly experienced in secure large scale cloud computing Creators of the largest ever documented database of medicinal
http://www.medchemica.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
1.4 seconds
16x16
32x32
Identity Protect Limited
Identity Protection Service
PO ●●●795
God●●●ing , Surrey, GU7 9GA
GB
View this contact
Identity Protect Limited
Identity Protection Service
PO ●●●795
God●●●ing , Surrey, GU7 9GA
GB
View this contact
Identity Protect Limited
Identity Protection Service
PO ●●●795
God●●●ing , Surrey, GU7 9GA
GB
View this contact
BUY YOUR DOMAIN
11
YEARS
10
MONTHS
11
DAYS
WEBFUSION LTD.
WHOIS : whois.123-reg.co.uk
REFERRED : http://www.123-reg.co.uk
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
15
SITE IP
91.197.228.161
LOAD TIME
1.439 sec
SCORE
6.2
Medchemica - Creating a step change in Medicinal Chemistry | medchemica.com Reviews
https://medchemica.com
Why Choose Us Founded in 2012 by experienced large Pharma medicinal and computational chemists to accelerate drug hunting by exploiting data driven knowledge Domain leaders in SAR knowledge extraction Highly experienced in secure large scale cloud computing Creators of the largest ever documented database of medicinal
medchemica.com
MedChemica - Creating a step change in Medicinal Chemistry
https://www.medchemica.com/salt.html
MedChemica Limited, A company registered in England and Wales, No. 8162245, Ebenezer House, Ryecroft, Newcastle-under-Lyme, Staffordshire ST5 2BE, England. Website Disclaimer.
MedChemica - Creating a step change in Medicinal Chemistry
https://www.medchemica.com/index.html
We have a strong and continuing desire:. To design drugs for the treatment of all diseases. To develop and exploit knowledge based design science to help our clients make the right compounds first time. To find technologies and methods to connect large pharma and emerging drug discovery units, and place them on the path to successful collaborations. To serve our client base in biotech, CRO, foundations, universities and large pharmaceutical companies. Over 140 Publications and Patents in.
MedChemica - Creating a step change in Medicinal Chemistry
https://www.medchemica.com/disclaimer.html
And www.medchemica.co.uk. Only for personal, non-commercial use. This website uses Javascript for navigation purposes and to provide anonymouse recording of visitor data. This is a comprehensive limitation of liability that applies to all damages of any kind, including (without limitation) compensatory, direct, indirect or consequential damages, loss of data, income or profit, loss of or damage to property and claims of third parties. This website was designed by http:/ www.notgotawebsiteyet.com.
MedChemica - Creating a step change in Medicinal Chemistry
https://www.medchemica.com/services.html
We offer a range of Medicinal and Computational Compound. Design services and have particular expertise in. Data mining for problem solving and reagent design. Application of QM methods to drug design issues. We really want to hear what your problems are and solve them. For the consortium with large pharm - Click SALT below. Lead Identification and Optimisation Chemistry Services. At the heart of our business is the SALT MINER consortium - click the RED banner - enabling us to.
MedChemica - Creating a step change in Medicinal Chemistry
https://www.medchemica.com/news.html
We are happy to announce that MedChemica is a partner of Horizon2020 Marie Skodowska-Curie ITN BIGCHEM network. We are looking for 10 doctoral (PhD) positions in Big Data Analysis in Chemistry. Please apply at BigChem Website. MedChemica is awarded a grant from the Technology Strategy Board (TSB). MedChemica helps the Protein Protein Interactions Network (PPI-Net). By researching and compiling a community document. And new interative network maps. Why did we call it that - read the story on our blog.
TOTAL PAGES IN THIS WEBSITE
7
Acta MedChemica: January 2013
http://medchemica.blogspot.com/2013_01_01_archive.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Friday, 25 January 2013. Protein Protein Interactions - Blue sky thinking from best. All of the talks should be posted on the web soon. Keep your eyes on www.ppi-net.org. Monday, 21 January 2013. Carlos A. Montanari. J Comput Aided Mol Des. 1 In the Pipeline.
Acta MedChemica: So why did we call it SALT MINER?
http://medchemica.blogspot.com/2013/06/so-why-did-we-call-it-salt-miner.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Wednesday, 26 June 2013. So why did we call it SALT MINER? KSCuMMP doesn't really work. We also work in a world of chem.-informatics and computation and there has been a long history of finding an amusing acronym for the ne. Here there are huge underground salt mi...
Acta MedChemica: Evidence Based Medicinal Chemistry
http://medchemica.blogspot.com/2013/05/evidence-based-medicinal-chemistry.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Monday, 13 May 2013. Evidence Based Medicinal Chemistry. Giving lectures is a mixed pleasure for me. Http:/ www.eyesopen.com/events/eurocup-2013. As Einstein said, "If you want elegance, find a tailor". Med Chem. Commun. It takes a lot of data and a lot of mining ...
Acta MedChemica: Fragment hopping, mapping waters in SBDD and Statistics
http://medchemica.blogspot.com/2013/05/fragment-hopping-mapping-waters-in-sbdd.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Monday, 20 May 2013. Fragment hopping, mapping waters in SBDD and Statistics. So the lecture went well and it's now online at http:/ lanyrd.com/2013/eurocup6/schbhf/ with all the others at EuroCUP at http:/ lanyrd.com/2013/eurocup6/. 1 In the Pipeline.
Acta MedChemica: Matched Molecular Pair Analysis in Drug Discovery
http://medchemica.blogspot.com/2013/04/matched-molecular-pair-analysis-in-drug.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Monday, 15 April 2013. Matched Molecular Pair Analysis in Drug Discovery. Http:/ www.sciencedirect.com/science/article/pii/S1359644613000937. Now that will improve your hERG! Subscribe to: Post Comments (Atom). Matched Molecular Pair Analysis in Drug Discovery.
Acta MedChemica: June 2013
http://medchemica.blogspot.com/2013_06_01_archive.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Wednesday, 26 June 2013. So why did we call it SALT MINER? KSCuMMP doesn't really work. We also work in a world of chem.-informatics and computation and there has been a long history of finding an amusing acronym for the ne. Here there are huge underground salt mi...
MedChemica - Creating a step change in Medicinal Chemistry
http://www.medchemica.co.uk/disclaimer.html
And www.medchemica.co.uk. Only for personal, non-commercial use. This website uses Javascript for navigation purposes and to provide anonymouse recording of visitor data. This is a comprehensive limitation of liability that applies to all damages of any kind, including (without limitation) compensatory, direct, indirect or consequential damages, loss of data, income or profit, loss of or damage to property and claims of third parties. This website was designed by http:/ www.notgotawebsiteyet.com.
Acta MedChemica: BioTechs moving into Alderley Park
http://medchemica.blogspot.com/2013/05/biotechs-moving-into-alderley-park.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Friday, 10 May 2013. BioTechs moving into Alderley Park. Http:/ www.genengnews.com/gen-news-highlights/az-giving-way-to-early-stage-biopharmas-in-cheshire/81248329/. Subscribe to: Post Comments (Atom). Fragment hopping, mapping waters in SBDD and Stati.
Acta MedChemica: February 2013
http://medchemica.blogspot.com/2013_02_01_archive.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Thursday, 21 February 2013. Piling in around a ring. What about electronic differences? The sigma meta and sigma para values for C 6. F0: sigma meta: 0.06 sigma para: -0.01. F1 (para): sigma meta: 0.12 sigma para: 0.06. F5: sigma meta: 0.26 sigma para: 0.27.
Acta MedChemica: April 2013
http://medchemica.blogspot.com/2013_04_01_archive.html
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Monday, 15 April 2013. Matched Molecular Pair Analysis in Drug Discovery. Http:/ www.sciencedirect.com/science/article/pii/S1359644613000937. Now that will improve your hERG! Thursday, 11 April 2013. Predicting Human Serum Albumin binding. 1 In the Pipeline.
TOTAL LINKS TO THIS WEBSITE
15
MedChemHot.Pakistan | HOT POSTS IN MEDICINAL CHEMISTRY AND LOVE PAKISTAN MED CHEMISTS, ALONG WITH WINDOW TO PAKISTAN
HOT POSTS IN MEDICINAL CHEMISTRY AND LOVE PAKISTAN MED CHEMISTS, ALONG WITH WINDOW TO PAKISTAN. August 8, 2015. 1H NMR FROM THE NET. 1H NMR PREDICT AND 13 C NMR PREDICT BELOW. Http:/ www.google.com/patents/WO2015063720A1? Enzalutamide is chemically described as 4-{3-[4-cyano-3-(trifluoromethyl)phenyl] -5 ,5 -dimethyl-4-oxo-2-sulfanylideneimidazolidin- 1 -yl } -2-fluoro-N-methylbenzamide of Formula I. Golden Root (Rhodiola rosea)…….a queen of adaptogenic herbs. July 29, 2014. Golden Root (Rhodiola rosea).
Acta MedChemica
Medchemica is company specialising in molecular design and analysis. We specialise in hypothesis based, data driven design, and developing the tools to enhance those approaches. This is our blog capturing what we're up to in a more relaxed way. Wednesday, 26 June 2013. So why did we call it SALT MINER? KSCuMMP doesn't really work. We also work in a world of chem.-informatics and computation and there has been a long history of finding an amusing acronym for the ne. Here there are huge underground salt mi...
MedChemica - Creating a step change in Medicinal Chemistry
We have a strong and continuing desire:. To design drugs for the treatment of all diseases. To develop and exploit knowledge based design science to help our clients make the right compounds first time. To find technologies and methods to connect large pharma and emerging drug discovery units, and place them on the path to successful collaborations. To serve our client base in biotech, CRO, foundations, universities and large pharmaceutical companies. Over 140 Publications and Patents in.
Medchemica - Creating a step change in Medicinal Chemistry
105;nfo@yourdomain.com. Creating A Step Change in Medicinal Chemistry. Publications & Patents. Publications & Patents. Publications & Patents. Publications & Patents. We develop and exploit knowledge based design science to help our clients make the right compounds first time every time. With over 50 years of combined experience in Drug Discovery and over 150 publications and patents to date, we work with our clients to deliver better solutions that save time and improved the quality of compounds produced.
Default Parallels Plesk Panel Page
Web Server's Default Page. This page is generated by Parallels Plesk Panel. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms. To find out more information. Hypervisor Virtualization technology for.
medcheminternational.blogspot.com
Medicinal Chemistry International
MEDICINAL CHEMISTRY AT ITS BEST, Tracks information on drugs on worldwide basis by Dr Anthony Melvin Crasto, worlddrugtracker, helping millions with websites, 6 million hits on google, one lakh connections worldwide, email amcrasto@gmail.com, call 91 9323115463 India. DRUG LEAD AND CHEMBASE. VIR SERIES .HEP C VIRUS 1/2. List of drugs 2012 FDA. List Of drugs 2014 FDA. Brand-Name Drug Patent Expiration Search. List of drugs 2013 FDA. Friday, 17 July 2015. Triphala : A Digestive Miracle. Widely used by natu...
丙二酸|苯丙酸|酰肼与二酰肼|1-茚酮|乙酸衍生物|缩水甘油醚|(甲基)丙烯酸酯|苯乙酮、二苯甲酮--盐城市麦迪科化学品制造有限公司
2,2,5-三甲基-1,5-二氧-4,6-二酮. 2,4,5,6-四氨基嘧啶硫酸盐.
MedChemNet | Drug discovery, therapeutic challenges, chemistry
MedChemNet the medicinal chemistry network. We use cookies on our website to ensure you have a good experience. Read our cookie policy. For more information or continue browsing. By continuing to browse our website you are consenting to our cookie policy. MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships. New drug approvals: December 2016.
